Patients should avoid a class of antibiotics called fluoroquinolones due to an increased risk of heart vessel tears associated with their use, the U.S. Food and Drug Administration warned. . . .
The risk for these ruptures rises with the use of fluoroquinolone antibiotics delivered by injection or as a pill, and the drugs “should not be used in patients at increased risk unless there are no other treatment options available,” the FDA added.